Ingevity CORP Form 4 insider transactions

Richard Allen White JR, SVP and President of Performance Chemicals at Ingevity Corp, reports transactions involving common stock and restricted stock units (RSUs) on February 28, 2024.

EVP and President of Performance Materials at Ingevity Corp, Stuart Edward Woodcock Jr., reports stock transactions including shares withheld for tax obligations and the grant of restricted stock units.

Christine Stunyo, SVP and Chief HR Officer of Ingevity Corp, disposed of 351 shares of common stock on February 28, 2024, to cover tax withholding obligations related to vested RSUs.

EVP, Gen. Counsel & Secretary Stacy Cozad reports acquisition and disposal of Ingevity Corp stock related to RSU vesting and tax obligations.

Mary Dean Hall, EVP & CFO of Ingevity Corp, reports acquisition and disposal of common stock related to vesting of restricted stock units and tax obligations.

John C. Fortson, President and CEO of Ingevity Corp, reports the vesting of restricted stock units and associated tax withholding, along with the grant of new restricted stock units.

Ingevity Corp's CEO, John C. Fortson, reported the disposal of 1,377 shares of common stock to cover tax obligations related to vested RSUs.

Stacy Cozad, EVP, Gen. Counsel & Secretary of Ingevity Corp, reports disposition of shares to cover tax obligations related to vested RSUs.

EVP Stuart Edward Woodcock Jr. of Ingevity Corp reports disposition of shares to cover tax obligations related to vested RSUs.

Richard Allen White JR, SVP and President of Performance Chemicals at Ingevity Corp, reports the disposal of 77 common stock shares to cover tax obligations related to vested RSUs.

Phillip John Platt, CAO & VP, Bus Transform Lead at Ingevity Corp, disposed of 81 shares to cover tax obligations related to vested RSUs.